Covenant Multifamily Offices’s Gilead Sciences GILD Stock Holding History

Covenant Multifamily Offices’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.84M	Sell	27,368 -1,979	-7%	-$139K	0.33%	52
2021 Q2	$2.02M	Sell	29,347 -2,876	-9%	-$192K	0.37%	48
2021 Q1	$2.08M	Buy	32,223 +5,196	+19%	+$335K	0.43%	39
2020 Q4	$1.57M	Buy	27,027 +1,887	+8%	+$114K	0.28%	50
2020 Q3	$1.59M	Buy	25,140 +1,040	+4%	+$72.1K	0.31%	42
2020 Q2	$1.85M	Sell	24,100 -6,189	-20%	-$474K	0.37%	41
2020 Q1	$2.26M	Sell	30,289 -33,070	-52%	-$2.29M	0.57%	21
2019 Q4	$4.12M	Buy	63,359 +29,318	+86%	+$1.91M	0.7%	19
2019 Q3	$2.16M	Buy	34,041 +234	+0.7%	+$15.3K	0.46%	26
2019 Q2	$2.28M	Buy	+33,807	New	+$2.22M	0.5%	21

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Covenant Multifamily Offices's GILD Position: Q3 2021 in Review

Covenant Multifamily Offices reduced its Gilead Sciences (GILD) stake by 6.7% in Q3 2021, selling an estimated $139K and leaving 27,368 shares worth $1.84M. The position accounts for 0.33% of the portfolio, ranked #52.

Covenant Multifamily Offices first reported a position in GILD in Q2 2019 and has held it in 10 quarters since. The position peaked at $4.12M in Q4 2019. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

Covenant Multifamily Offices held 27,368 shares of Gilead Sciences worth $1.84M as of Q3 2021.
Covenant Multifamily Offices sold 1,979 Gilead Sciences shares in Q3 2021, an estimated $139K.
Gilead Sciences made up 0.33% of Covenant Multifamily Offices's portfolio in Q3 2021, its #52 holding.
Covenant Multifamily Offices first reported a position in Gilead Sciences in Q2 2019 and has held it in 10 quarters since.
Covenant Multifamily Offices's Gilead Sciences position peaked at $4.12M in Q4 2019.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.